Endpoint
Endpoint is a term used in clinical trials to refer to an event or outcome that can be measured objectively to determine whether the intervention being studied is beneficial. The endpoints of a clinical trial are usually included in the study objectives. Some examples of endpoints are survival, improvements in quality of life, relief of symptoms, and disappearance of the tumor.
Types of Endpoints[edit | edit source]
There are several types of endpoints that can be used in clinical trials, including:
- Primary Endpoint: This is the main result that is measured at the end of a study to see if a given treatment worked.
- Secondary Endpoint: These are the measures that are of secondary interest or that are not as important as the primary endpoint.
- Tertiary Endpoint: These are the endpoints that are only looked at as exploratory information.
Choosing the Right Endpoint[edit | edit source]
The choice of endpoint is crucial in the design of a clinical trial. The endpoint should be relevant to the patient and the disease being studied. It should also be measurable and sensitive to changes in the patient's condition. The choice of endpoint can also affect the length and cost of the trial, as well as the strength of the evidence generated.
Endpoints in Different Phases of Clinical Trials[edit | edit source]
In different phases of clinical trials, different types of endpoints are used. For example, in Phase I trials, the endpoint is usually safety, while in Phase II trials, the endpoint is usually efficacy. In Phase III trials, the endpoint is usually the comparison of the new treatment with the standard treatment.
Challenges in Defining Endpoints[edit | edit source]
There are several challenges in defining endpoints for clinical trials. One challenge is that the endpoint may not be directly observable, but must be inferred from other measurements. Another challenge is that the endpoint may not be a single event, but a composite of several events.
See Also[edit | edit source]
- Clinical trial
- Primary Endpoint
- Secondary Endpoint
- Tertiary Endpoint
- Phase I trials
- Phase II trials
- Phase III trials
Endpoint Resources | |
---|---|
|
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD